Avastin bevacizumab: Completed Phase III enrollment

Roche disclosed that last quarter it completed enrollment of 1,800 patients in a double-blind, placebo-controlled, international Phase III trial (GOG-0218) evaluating paclitaxel and carboplatin with o...